From previous study, p-ERK1/2 and Ki-67 are highly expressed in nasopharyngeal carcinoma patients and ERK1/2 signaling pathway participates in the NPC proliferation and apoptosis [34]. This evidence concerns the gene MKI67 and nasopharyngeal carcinoma.